NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer trial tests if less treatment is just as good
Disease control Not yet recruitingThis study is testing if a shorter treatment schedule with the immunotherapy drug tislelizumab, combined with standard chemotherapy and radiation, works as well as the standard, longer schedule for people with advanced nasopharyngeal cancer. It will involve about 418 adults to se…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo trial aims to tame aggressive nasal cancer
Disease control Not yet recruitingThis study is testing whether adding the drug anlotinib to the current standard treatment (immunotherapy plus chemotherapy and radiation) works better for people with high-risk, locally advanced nasopharyngeal cancer. It will enroll 412 adults to compare the two treatment approac…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC